Synexus Opens Dedicated Clinical Research Site in Frankfurt, Germany

Synexus, a Site Management Organization (SMO), dedicated to the recruitment of patients’ and hands-on conduct of clinical trials on behalf of pharmaceutical, biotech and CRO clients, has opened a new Dedicated Clinical Research Site in Frankfurt. The state-of-the-art expansion into new facilities in Frankfurt supports the global Synexus mission to be the patient’s choice for clinical research and to offer customers efficiency in the clinical trial process by recruiting more engaged patients from more capable sites.

At the formal opening of the new Synexus Frankfurt Clinical Research Site, Dr Christophe Berthoux, CEO of Synexus, was joined by Christoph Dietrich, the Managing Director of Synexus Germany and by Nicole Freibott, Head of the Synexus Frankfurt Clinical Research Site. Representatives of pharma, CRO, partner GPs and specialists were present to celebrate this important occasion and to reiterate the company’s long term plans to build service capability in this country where pharmaceutical and biotech companies are continuing to conduct a large number of clinical trials.

The opening, attended by clients, network doctors and business partners, was performed by Christophe Berthoux, CEO of Synexus, who commented “Germany is one of our leading locations for running clinical trials with its excellent medical expertise, a history of running high quality clinical trials and good access to patients. Europe continues to be a favored region for our clients in the running of their global clinical trials and we are planning to further develop our business in Germany.”

Synexus German Managing Director Christoph Dietrich commented: “This is a further step in our plan to update and expand our very successful network of clinics across Germany by providing modern clinics which benefit both our patients and our clients. Our success in bringing clinical trials to Germany is dependent on our ability to deliver engaged patients and high quality data. We have put in place a proven patient engagement program which improves the patient experience and it is these added-value extras which really pay dividends in terms of client success.”

The new clinic, which will be managed by Nicole Freibott, is placed ideally for easy patient access as it is located in the inner city, close to the popular shopping street Zeil with immediate access to public transport and parking facilities.
  • <<
  • >>